References
- Sugimoto I., Kuchiki A., Nakagawa H., Tohgo H., Kondo S., Iwane I., Takahashi K. Drug Dev. Ind. Pharm. 1980; 6(2)137
- Foster T. S., Hamann S. R., Richards V. R., Bryant P. J., Graves D. A., Mc Allister R. G. J. Clin. Pharmacol. 1983; 23: 161
- Raemsch K. D., Sommer J. Calcium Antagonists Supp II Hypertension 1983; 5(4)11–18
- Sumnu M. STP Pharma 1986; 2(14)214
- Hasegawa A., Nakagawa H., Sugimoto I. Chem. Pharm. Bull. 1985; 33(4)1615
- Kohri N., Mori K. I., Miyazaki K., Arita T. J. Pharm. Sci. 1986; 75(1)57
- Umeda T., Yokoyama T., Ohnishi N., Kuroda T., Kita Y., K Kuroda, Asada S. Chem. Pharm. Bull. 1985; 33(9)3953
- Vila J. L., Martinez R., Concheiro A., Remuñán C. III European Congress of Biopharmaceutics and Pharmacokinetics Proceedings 1987; 1: 69
- Yamaoka K., Nakagawa T., Uno T. J. Pharmacokin. Biopharm. 1978; 6: 547
- Tanigawara Y., Yamaoka K., Nakagawa T., Uno T. J. Pharm. Sci. 1982; 71(10)1129
- Karba R., Bremsak F., Matko D., Mrhar A., Kozjek F. 7th Triennial World Congress of the IFAC 1978; 1: 557
- Mrhar A., Kozjek F., Priniozic S., Karba R. Acta Pharmaceutica Yugoslavija 1987; 37: 319
- Miyazaki K., Kohri N., Namura A., Yasuda H. J. Chromatogr. 1984; 310: 219
- Primozic S., Karba R., Mc Namara P. J., Kozjek F., Mrhar A., Istenic M. Third European congress of Biopharmaceutics and pharmacokinetics Proceedings 1987; II: 363
- Riegelman S., Collier P. J. Pharmacokinet. Biopharm. 1980; 8(5)509
- Mrhar A., Kozjek F., Karba R., Kmetec V. Proc. 1984 Summer Computer Simulation Conference, Boston, Mass, 1984, 2, 775
- Jakobsen P., Pedersen O. L., Mikkelsen E. J. Chrornatogr. 1979; 162: 81
- Snedden W., Femández P. G., Brenda A., Kim B. K. Clinical and Investigative Medicine 1984; 7(3)
- Brown G. R., Fraser D. G., Castile J. A., Gaudreault P., Platt D. R., Friedman P. A. Int. J. Clin. Pharmacol. Ther. Toxicol. 1986; 24(6)283
- Hoyo-Vadillo C., Castañeda G., Herrera J. E. J. V., Gárate A., Moreno F., Chávez, Hong E. J. Clin. Pharmacol. 1989; 29: 816
- Kleinbloesem C., Van Brummelen J. A.P., Van De Linde P., Voogd J., Breimer D. D. Clin. Pharmacol. Ther. 1984; 35: 742
- Mc Allister R. G. J. Cardiov. Pharmacol. 1982; 4: 5340
- Stern Z., Zylber-Katz E., Levy M. J. Clin. Pharmacol. Ther. Toxicol. 1984; 22: 198
- Taburet A. M., Singlas E., Colin J. N., Benzet O., Thibonnier M., Corvol P. Hypertension 1983; 5: 11–29
- Nielsen-Kudsk F., Askholt J. Acta Pharmacol. et Toxicol. 1981; 48: 330
- Finhilt P., Solvang S. J. Pharma Sci. 1968; 57: 1322
- Takahashi T., Uezono Y., Fujioka H. H. Yakuzaigaku 1983; 43: 61
- Kozjek F., Karba R., Kristl A., Mrhar A., Primozic S. III European Congress of Biopharmaceutics and Pharmacokinetics Proceedings 1987; II: 366
- Venho V. M. K., Eriksson H. Int. Pharm J. 1986; 30: 91
- Mueda T., Tukenaka H., Yamahira Y., Noguchi T. J. Pharm. Sci. 1979; 68(10)1286
- Husegawa A., Nakagawa H., Suginioto I. Chem. Pharm. Bull. 1985; 33(4)1615
- Janicki P. K., Siembab D., Paulo E. A., Krascik P. Pharmacology 1988; 36: 183
- Kondo S., Sugimoto I. J. Pharmacobio-Dyn 1987; l0: 462
- Patzche K., Duhm B., Maul W., Medertwald H., Wegnwr L. A. 2nd International Adalat Symposium. 1975, 27
- Sugimoto I., Sasaki K., Kuchiki A., Ishihara T., Nakagawa H. Chem. Pharm Bull. 1982; 30(12)4479
- Gibaldi M., Feldman S. J. Pharm. Sci. 1969; 58: 1477
- Gibaldi M., Boyes R. N., Feldman S. J. Pharm Sci. 1971; 60: 1338
- Skelly J. P. Oral Sustained Release Formulations: Design and Evaluation, A. Yacobi, E. Halperin-Walega. Pergamon Press, New York 1988; 57
- Steinijans V. W., Konstanz D. Oral controlled Release Products: Therapeutic and Biopharmaceutic Assessment, U. Gundert-Remy, H. Möller. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart 1990; 99